Excess Ticagrelor Mortality in the Food and Drug Administration Adverse Event Reporting System: Time to Recount PLATO Trial Deaths.

MLA

Serebruany, Victor L., et al. “Excess Ticagrelor Mortality in the Food and Drug Administration Adverse Event Reporting System: Time to Recount PLATO Trial Deaths.” The American Journal of Medicine, vol. 130, no. 6, June 2017, pp. e245–46. EBSCOhost, https://doi.org/10.1016/j.amjmed.2016.12.037.

APA

Serebruany, V. L., Fortmann, S. D., Cherepanov, V., Litvinov, O., Kim, M. H., & Marciniak, T. A. (2017). Excess Ticagrelor Mortality in the Food and Drug Administration Adverse Event Reporting System: Time to Recount PLATO Trial Deaths. The American Journal of Medicine, 130(6), e245–e246. https://doi.org/10.1016/j.amjmed.2016.12.037

Chicago

Serebruany, Victor L, Seth D Fortmann, Vasily Cherepanov, Oleg Litvinov, Moo Hyun Kim, and Thomas A Marciniak. 2017. “Excess Ticagrelor Mortality in the Food and Drug Administration Adverse Event Reporting System: Time to Recount PLATO Trial Deaths.” The American Journal of Medicine 130 (6): e245–46. doi:10.1016/j.amjmed.2016.12.037.